Title for MeetingAbstracts
Alphabetical listing of titles
Reverse transcriptase genotype after multiple, sequential nucleoside analog drugs and the response to HAART in ACTG 364.
Reverse Transcriptase Resistance Mutation M184V Seems to Delay the Selection of Thymidine-Analogue Mutations (TAM) in Children with Subtype C HIV-1.
Reverse transcriptase sequence analysis of HIV isolates from a single rural cohort of Western Australian aboriginals.
Reverse transcriptase-associated ribonuclease H activity as a therapeutic target.
Reverse transcriptase-inhibiting antibody and its role as prognostic indicator for progression to AIDS.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for Diagnosis of Human Rhinovirus (HRV) Infections in Children.
Reverse transcription factories in cell-to-cell HIV infection.
Reverse transcription factories in cell-to-cell HIV infection.
Reverse transcription strand displacement amplification (RT-SDA) for rapid and sensitive detection of HIV-1 RNA.
Reversibility of peripheral fat wasting (lipoatrophy) on stopping stavudine therapy.
Reversibility of protease inhibitor (PI) lipodystrophy syndrome on stopping PIs or switching to nelfinavir.
Reversible and irreversible inactivation of integrated HIV-1 genomes by DNA CPG methylation: possible mechanism for latency.
Reversible anergy of HIV-specific CD4+ T-cells detected by class II tetramers.
Reversible inhibition of acute and chronic HIV-1 infection by an inhibitor of virus protease.
Reversible Predominance of CXCR4 Utilising Variants in a Non-Responsive Dual Tropic Patient Receiving the CCR5 Antagonist UK-427,857.
Reversing the burden of proof. Why does the private sector in Africa NOT provide HAART to its employees?
Reversion of CTL escape mutant simian immunodeficiency virus (SIV) in vivo: Implications for HIV vaccine development.
Reversion of Cutaneous Anergy and the Tuberculin Test after Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-Infected Patients with CD4 count <50/micro-l.
Reversion of Glycopeptide (Gp) Intermediate-Resistant Staphylococcus aureus (GISA) Associated with Loss of Type 5 Capsule.
Reversion of HIV-1 with mutations in the tryptophan-rich region of gp41.
Reversion of lipodistrophy after switching HIV-1 protease inhibitors to nevrirapine.
Reversion of MHC class I downregulation in HIV infected cells by low temperature or peptides.
Reversion of SI phenotype to NSI in patients with HIV-1 infection.
Reversion to pre-HAART population levels of viremia concomitant with recent changes in ART prescribing practices.
Review : A decade of programme interventions to prevent HIV transmission among young people.
Review and commentary on the quality of the literature: positron emission tomography in clinical oncology.
Review of 33 HIV positive patients referred for cardiac assessment.
Review of a workplace based antiretroviral program: the Kenya Ports Authority experience.
Review of antiretroviral therapy (ART) guidelines in selected countries of Africa and the Caribbean: A challenge for optimizing treatment and product supply.
Review of Antiretroviral Therapy in the Private Sector in Nairobi, Kenya.